Table 3

Intention to treat analysis of enrolled study subjects
Completion of the study
 Baseline (n = 87) Normal echogenic response Fatty liver
Tocotrienols (n = 43) 15/43 28/43
34.9% 65.1%
Placebo (n = 44) 8/44 36/44
18.2% 81.8%
Tocotrienols vs Placebo P = 0.038

Drop-out subjects were computed as having an unchanged diagnosis of fatty liver from baseline.

[Helmert-Pearson’s Chi Square; Numbers’09, GraphPad].

Magosso et al.

Magosso et al. Nutrition Journal 2013 12:166   doi:10.1186/1475-2891-12-166

Open Data